Annexon Highlights Leadership in Advancing Clinical Research and Education for Guillain-Barr Syndrome (GBS) at American Academy of Neurology (AAN) 2025 Annual Meeting
April 03, 2025 18:18 ET | Source: Annexon Biosciences Oral Plenary Presentation…
Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference
MORRISVILLE, N.C., April 01, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA),…
3D Investment Publishes Corporate Value Enhancement Plan for Toho Holdings
TOKYO--(BUSINESS WIRE)--3D Investment Partners Pte. Ltd. (“3D” or “we”), the investment manager…
Punta Cana to host IOC Session in 2027
21 March 2025 - Punta Cana, Dominican Republic, has been officially selected to…
French Alps 2030 delivers first report to IOC Executive Board
17 March 2025 - The recently created Organising Committee for the Olympic Winter…
Data of InnoCare’s ICP-488 for the Treatment of Psoriasis Presented at Late Breaking Oral Presentation of 2025 AAD
BEIJING--(BUSINESS WIRE)--InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing…
LEO Pharma Presents New Late-Breaking Delgocitinib Cream Data For the Third Consecutive Year at AAD 2025
The post hoc analysis investigated treatment responses in a patient subgroup with…
Incyte Announces Results of Phase 3 Clinical Trials Evaluating Ruxolitinib Cream 1.5% (Opzelura) in Patients with Prurigo Nodularis (PN) at 2025 American Academy of Dermatology Annual Meeting
- Full data from the Phase 3 TRuE-PN1 study, presented today in…
Drs. Jeffrey Lieberman, M.D. and David Sinclair, Ph.D. to PresentThe New Frontier of Longevity Science: Living Well Beyond Your Years at SXSW 2025
AUSTIN, Texas, March 07, 2025 (GLOBE NEWSWIRE) -- Renowned neuroscientist, psychiatrist, and…
BigBear.ai Announces Fourth Quarter, And Full Year 2024 Results, And Provides 2025 Outlook
4Q 24 revenue of $43.8 million (4Q 23 $40.6 million) +8% year-over-year…